Edward Copelan, M.D.
| Appointed: |
2007 |
| Gender: |
Male |
| Languages: |
English |
Hematologic Oncology and Blood Disorders
Biographical Sketch
Edward A. Copelan, MD, is the Director of the Acute Leukemia Program at Cleveland Clinic. He received his medical degree in 1977 from Tufts University.
Education & Fellowships
| Medical School: | Tufts University School of Medicine, Boston, MA |
|
| Internship: | The Ohio State University Hospitals, Internal Medicine, Columbus, OH |
| Residency: | The Ohio State University Hospitals, Internal Medicine, Columbus, OH |
| Fellowship: | The Ohio State University Hospitals, Hematology/Oncology, Columbus, OH |
| Fellowship: | University of California Los Angeles Medical Center (UCLA), Bone Marrow Transplant, Westwood, CA |
| Other Education: | (Undergraduate) Muhlenberg College, Allentown, PA |
Certifications
Medical Oncology
Hematology
Internal Medicine
Specialty Interests
Acute leukemias, chronic myelogenous leukemia, Hematopoietic Stem Cell Transplantation, lymphoma, Multiple Myeloma.
Innovations & Patents
Kolattukudy PE, Markaryan AN, Copelan EA, Ceselski SK, Inventors. Prevention of Invasive Pulmonary Aspergillosis with Serine Proteinase Inhibitors; filed June 7, 1995; Patent No. 5,739,283; April 14, 1998
Awards & Honors
- BS, magna cum laude, Muhlenberg College
- Tufts University with honors
- Department of Medicine Award of Merit for Outstanding Performance during Residency Training
- Fellowship, Leukemia Society of America
- Junior Faculty Fellowship, American Cancer Society
- Clinical Investigator Award, National Cancer Institute
- Teacher of the Year, OSU Medical Housestaff, 1985-1986
- Dean's Award for Teaching Excellence, 1987-1988
- Executive Committee of the Center for International Bone Marrow Transplantation Registry, 2004-Present
- NIH Study Section Member, Manpower and Training, 2002-2006
- America’s Top Physicians, Consumers’ Research Council of America, 2006
Professional Memberships
-
American Society of Hematology, 1986-Present
- American College of Physicians, 1984-Present
- American Society of Clinical Oncology, 1991-Present
- American Society for Blood and Marrow Transplantation, 1992-Present
- International Bone Marrow Transplant Registry, 1992-Present
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/1/2008, Dr. Copelan has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Copelan receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
